GGrantIndex
← Search

Gordon Research Conference on Tetrapyrroles

$10,000R13FY2002HLNIH

Gordon Research Conferences, East Greenwich RI

Investigators

Abstract

DESCRIPTION (provided by applicant): This application requests support for the 19th Gordon Research Conference on the Chemistry and Biology of Tetrapyrroles, to be held at Salve Regina University, Newport, RI, from July 14-19, 2002. This biennial interdisciplinary conference has stimulated collaborations between basic biologists, chemists and clinicians interested in Tetrapyrroles for more than three decades. In association with proteins, Tetrapyrroles serve diverse roles as biological redox catalysts, for harvesting of light energy, for oxygen activation/delivery and as signaling molecules. Free Tetrapyrroles are also essential nutrients (e.g., vitamin B12), serve as regulators of gene expression (e.g., hemes) and have been utilized as therapeutic agents (e.g., photodynamic cancer therapy, target delivery of radionuclides). Owing to their photodynamic activity, toxicity and lipophilicity, the accumulation of Tetrapyrroles (e.g., porphyrins, bilirubin) is associated with numerous pathologies of the skin, liver and brain. For these reasons, this conference represents an important venue for exchange between basic and applied researchers on Tetrapyrroles and for refinement of new tools and therapies which are under development by the biomedical industry. Funds requested in this application are targeted to support investigators who have not previously had the opportunity to attend this conference. A special effort has been placed in promoting participation of young investigators. One of two new sessions has been added to highlight recent developments and what the future promises in genomics, proteomics and protein technologies; the second new session will focus on the molecular regulatory mechanisms of erythropoiesis and apoptosis and their implications in relation to blood and liver disorders. There will be 22 invited speakers, a plenary lecturer and 8 discussion leaders, who have been selected for their scientific excellence, recent innovative work and breadth of the program. The remaining 100 conferees will be chosen to ensure a broad representation of women, ethnicity and young scientists from various disciplines in academia, medical research institutions and industry. Strengths of this ongoing Gordon conference are its disciplinary diversity, focus on new unpublished work, time for discussion, informal atmosphere, and ban on dissemination of conference proceeding.

View original record on NIH RePORTER →